Cholecystokinin enhanced hepatobiliary scanning with ejection fraction calculation as an indicator of disease of the gallbladder

Chronic acalculous cholecystitis represents 5 to 20 per cent of electively treated diseases of the gallbladder. A 70 per cent success rate in relieving these patients of chronic pain was reported when surgical treatment was recommended based on symptoms alone. The cholecystokinin ejection fraction,...

Full description

Saved in:
Bibliographic Details
Published inSurgery, gynecology & obstetrics Vol. 172; no. 1; p. 21
Main Authors Zech, E R, Simmons, L B, Kendrick, R R, Soballe, P W, Olcese, J A, Goff, 2nd, W B, Lawrence, D P, DeWeese, R A
Format Journal Article
LanguageEnglish
Published United States 01.01.1991
Subjects
Adult
Cholecystectomy
Cholecystitis - diagnostic imaging
Cholecystitis - epidemiology
Cholecystitis - surgery
Cholecystokinin - administration & dosage
Cholecystokinin - pharmacokinetics
Evaluation Studies as Topic
Female
Gallbladder - physiopathology
Humans
Male
Middle Aged
Muscle Contraction
Predictive Value of Tests
Radionuclide Imaging - standards
Rheology
Stroke Volume
Online AccessGet more information

Cover

More Information
Summary:Chronic acalculous cholecystitis represents 5 to 20 per cent of electively treated diseases of the gallbladder. A 70 per cent success rate in relieving these patients of chronic pain was reported when surgical treatment was recommended based on symptoms alone. The cholecystokinin ejection fraction, which is a quantitative measure of emptying of the gallbladder, was 95 per cent accurate in predicting which patients would be relieved of symptoms by surgical treatment. In this study, we report our consecutive experience during a 20 month period with 83 patients.
ISSN:0039-6087